Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1539 Compare Versions

Only one version of the bill is available at this time.
OldNewDifferences
11 I
22 119THCONGRESS
33 1
44 STSESSION H. R. 1539
55 To amend the Federal Food, Drug, and Cosmetic Act to expand the types
66 of devices for which required labeling may be made available solely
77 by electronic means, and for other purposes.
88 IN THE HOUSE OF REPRESENTATIVES
99 FEBRUARY24, 2025
1010 Mr. O
1111 BERNOLTE(for himself, Mr. MULLIN, Mr. CRENSHAW, and Ms. CRAIG)
1212 introduced the following bill; which was referred to the Committee on En-
1313 ergy and Commerce
1414 A BILL
1515 To amend the Federal Food, Drug, and Cosmetic Act to
1616 expand the types of devices for which required labeling
1717 may be made available solely by electronic means, and
1818 for other purposes.
1919 Be it enacted by the Senate and House of Representa-1
2020 tives of the United States of America in Congress assembled, 2
2121 SECTION 1. SHORT TITLE. 3
2222 This Act may be cited as the ‘‘Medical Device Elec-4
2323 tronic Labeling Act’’. 5
2424 VerDate Sep 11 2014 03:45 Mar 13, 2025 Jkt 059200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H1539.IH H1539
2525 kjohnson on DSK7ZCZBW3PROD with $$_JOB 2
2626 •HR 1539 IH
2727 SEC. 2. ALLOWING REQUIRED LABELING OF DEVICES TO 1
2828 BE MADE AVAILABLE SOLELY BY ELEC-2
2929 TRONIC MEANS. 3
3030 Section 502(f) of the Federal Food, Drug, and Cos-4
3131 metic Act (21 U.S.C. 352(f)) is amended to read as fol-5
3232 lows: 6
3333 ‘‘(f)(1) Unless its labeling bears (A) adequate direc-7
3434 tions for use; and (B) such adequate warnings against use 8
3535 in those pathological conditions or by children where its 9
3636 use may be dangerous to health, or against unsafe dosage 10
3737 or methods or duration of administration or application, 11
3838 in such manner and form, as are necessary for the protec-12
3939 tion of users, except that where any requirement of clause 13
4040 (A) of this subparagraph, as applied to any drug or device, 14
4141 is not necessary for the protection of the public health, 15
4242 the Secretary shall promulgate regulations exempting such 16
4343 drug or device from such requirement. 17
4444 ‘‘(2) Subject to subparagraph (3), required labeling 18
4545 for devices (including in vitro diagnostic devices) may be 19
4646 made available solely by electronic means, provided that— 20
4747 ‘‘(A) such required labeling is readily accessible 21
4848 to intended users of such devices; 22
4949 ‘‘(B) the manufacturer affords intended users 23
5050 of such devices the opportunity to request the re-24
5151 quired labeling in paper form, and upon such re-25
5252 VerDate Sep 11 2014 03:45 Mar 13, 2025 Jkt 059200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H1539.IH H1539
5353 kjohnson on DSK7ZCZBW3PROD with $$_JOB 3
5454 •HR 1539 IH
5555 quest, promptly provides the requested information 1
5656 in paper form without additional cost; and 2
5757 ‘‘(C) the label affixed to the device or its imme-3
5858 diate container includes all information in compli-4
5959 ance with this Act and the regulations thereunder or 5
6060 any applicable order of the Secretary under subpara-6
6161 graph (3)(A). 7
6262 ‘‘(3)(A) With respect to devices for which labeling is 8
6363 made available solely by electronic means, the Secretary 9
6464 may issue an order establishing requirements in addition 10
6565 to, or exceptions from, the requirements under subpara-11
6666 graph (2) for the label affixed to a device type. 12
6767 ‘‘(B) Notwithstanding subchapter II of chapter 5 of 13
6868 title 5, United States Code, such order shall be published 14
6969 in the Federal Register, following publication of a pro-15
7070 posed order in the Federal Register and consideration of 16
7171 comments to a public docket. 17
7272 ‘‘(C) Such order may require the label of a device 18
7373 to contain certain information or comply with certain con-19
7474 ditions only if the Secretary determines such requirement 20
7575 is necessary to provide a reasonable assurance of the safe-21
7676 ty and effectiveness of the device.’’. 22
7777 Æ
7878 VerDate Sep 11 2014 03:45 Mar 13, 2025 Jkt 059200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6301 E:\BILLS\H1539.IH H1539
7979 kjohnson on DSK7ZCZBW3PROD with $$_JOB